ID-CRU: In The News

The Department of Medicine recently celebrated outstanding faculty whose contributions foster excellence in medical education, clinical care and research at Washington University School of Medicine. Infectious Diseases (ID) faculty who received in-person recognition are listed below. View all the 2023 DOM Faculty Recognition Reception

Researchers began working on a breath test device — made with 3D printers — after receiving a grant from the National Institutes of Health (NIH) in August 2020, during the first year of the pandemic. Since receiving the grant, they’ve tested prototypes in the laboratory and in the Washington University Infectious Diseases Clinical Research Unit. The […]

A new clinic that offers care for patients with Non-tuberculous mycobacteria pulmonary disease (NTM-PD) is scheduling appointments in the Pulmonary Outpatient Clinic in the Center for Advanced Medicine. The clinic is a joint effort between Washington University physicians Carlos Mejia, MD, assistant professor in the division of infectious diseases; Thomas Bailey, MD, professor of medicine in […]

“Rachel Presti, MD, PHD is the director of Washington University’s Infectious Diseases Clinical Research Unit and principal investigator for the COVID-19 vaccine trials. Presti and Frey are coordinating so the two institutions can lead different vaccine trials.”

As U.S. scientists ramp up a national effort to evaluate COVID-19 vaccine candidates at clinical trial sites across the country, researchers at Washington University School of Medicine in St. Louis and the Saint Louis University Center for Vaccine Development have been tapped to join the historic effort to find a COVID-19 vaccine that can prevent […]

HPTN 083 Study Demonstrates Superiority of Cabotegravir for the Prevention of HIV . Both cabotegravir and oral tenofovir/emtricitabine (TDF/FTC) have high efficacy for pre-exposure prophylaxis (PrEP). Researchers from the HIV Prevention Trials Network (HPTN) announced today that the HPTN 083 clinical trial showed that a pre-exposure prophylaxis (PrEP) regimen containing  long-acting cabotegravir (CAB LA) injected […]

In early March, just as the pandemic was gaining steam in the St. Louis region, Jane O’Halloran, MD, PhD, an assistant professor of medicine, and Philip Mudd, MD, PhD, assistant professor of emergency medicine, met to discuss the possibility of creating a COVID-19 specimen bank. Two and a half weeks later, they began collecting their […]

Philip Mudd, MD, PhD, above, an assistant professor of emergency medicine, and his colleague, Jane O’Halloran, MD, PhD, assistant professor of medicine, infectious diseases specialist, have led efforts to create a repository for storing and managing specimens collected from patients with COVID-19. To date, more than 7,000 samples, including blood, urine and saliva specimens, have […]

COVID-19 survivors are needed to donate blood plasma. Infectious diseases physicians at Washington University School of Medicine in St. Louis have developed an expanded access program to give blood plasma from COVID-19 survivors to critically ill patients. Infectious diseases physicians at Washington University School of Medicine in St. Louis have developed an expanded access program […]

Cigna/Express Scripts provided the drugs; open to COVID-19 patients at Barnes-Jewish Hospital Washington University School of Medicine in St. Louis is launching a clinical trial for patients hospitalized with COVID-19 at Barnes-Jewish Hospital. The trial will investigate the effectiveness of different combinations of the antimalarial drugs chloroquine and hydroxychloroquine and the antibiotic azithromycin in treating […]

Rachel Presti, MD, PhD and the Infectious Diseases Clinical Research Team collaborate in $3.4 million effort to make a better flu vaccine